Home/Filings/4/0001415889-24-025140
4//SEC Filing

PARMAR KUSH 4

Accession 0001415889-24-025140

CIK 0001736730other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 5:56 PM ET

Size

23.2 KB

Accession

0001415889-24-025140

Insider Transaction Report

Form 4
Period: 2024-10-15
Transactions
  • Conversion

    Series A Prime Preferred Stock

    2024-10-1515,002,1660 total(indirect: By 5AM Ventures VI, L.P.)
    Common Stock (1,337,592 underlying)
  • Conversion

    Series B Preferred Stock

    2024-10-153,395,8160 total(indirect: By 5AM Opportunities II, L.P.)
    Common Stock (302,770 underlying)
  • Conversion

    Common Stock

    2024-10-15+302,770302,770 total(indirect: By 5AM Opportunities II, L.P.)
  • Conversion

    Series B Preferred Stock

    2024-10-154,244,7700 total(indirect: By 5AM Ventures VI, L.P.)
    Common Stock (378,463 underlying)
  • Purchase

    Common Stock

    2024-10-15$11.00/sh+909,090$9,999,9902,625,145 total(indirect: By 5AM Ventures VI, L.P.)
  • Conversion

    Common Stock

    2024-10-15+1,716,0551,716,055 total(indirect: By 5AM Ventures VI, L.P.)
Transactions
  • Conversion

    Series B Preferred Stock

    2024-10-153,395,8160 total(indirect: By 5AM Opportunities II, L.P.)
    Common Stock (302,770 underlying)
  • Purchase

    Common Stock

    2024-10-15$11.00/sh+909,090$9,999,9902,625,145 total(indirect: By 5AM Ventures VI, L.P.)
  • Conversion

    Series B Preferred Stock

    2024-10-154,244,7700 total(indirect: By 5AM Ventures VI, L.P.)
    Common Stock (378,463 underlying)
  • Conversion

    Common Stock

    2024-10-15+1,716,0551,716,055 total(indirect: By 5AM Ventures VI, L.P.)
  • Conversion

    Common Stock

    2024-10-15+302,770302,770 total(indirect: By 5AM Opportunities II, L.P.)
  • Conversion

    Series A Prime Preferred Stock

    2024-10-1515,002,1660 total(indirect: By 5AM Ventures VI, L.P.)
    Common Stock (1,337,592 underlying)
Transactions
  • Conversion

    Series B Preferred Stock

    2024-10-154,244,7700 total(indirect: By 5AM Ventures VI, L.P.)
    Common Stock (378,463 underlying)
  • Conversion

    Common Stock

    2024-10-15+1,716,0551,716,055 total(indirect: By 5AM Ventures VI, L.P.)
  • Purchase

    Common Stock

    2024-10-15$11.00/sh+909,090$9,999,9902,625,145 total(indirect: By 5AM Ventures VI, L.P.)
  • Conversion

    Common Stock

    2024-10-15+302,770302,770 total(indirect: By 5AM Opportunities II, L.P.)
  • Conversion

    Series A Prime Preferred Stock

    2024-10-1515,002,1660 total(indirect: By 5AM Ventures VI, L.P.)
    Common Stock (1,337,592 underlying)
  • Conversion

    Series B Preferred Stock

    2024-10-153,395,8160 total(indirect: By 5AM Opportunities II, L.P.)
    Common Stock (302,770 underlying)
PARMAR KUSH
10% Owner
Transactions
  • Purchase

    Common Stock

    2024-10-15$11.00/sh+909,090$9,999,9902,625,145 total(indirect: By 5AM Ventures VI, L.P.)
  • Conversion

    Series A Prime Preferred Stock

    2024-10-1515,002,1660 total(indirect: By 5AM Ventures VI, L.P.)
    Common Stock (1,337,592 underlying)
  • Conversion

    Common Stock

    2024-10-15+1,716,0551,716,055 total(indirect: By 5AM Ventures VI, L.P.)
  • Conversion

    Common Stock

    2024-10-15+302,770302,770 total(indirect: By 5AM Opportunities II, L.P.)
  • Conversion

    Series B Preferred Stock

    2024-10-153,395,8160 total(indirect: By 5AM Opportunities II, L.P.)
    Common Stock (302,770 underlying)
  • Conversion

    Series B Preferred Stock

    2024-10-154,244,7700 total(indirect: By 5AM Ventures VI, L.P.)
    Common Stock (378,463 underlying)
Transactions
  • Conversion

    Common Stock

    2024-10-15+1,716,0551,716,055 total(indirect: By 5AM Ventures VI, L.P.)
  • Purchase

    Common Stock

    2024-10-15$11.00/sh+909,090$9,999,9902,625,145 total(indirect: By 5AM Ventures VI, L.P.)
  • Conversion

    Series A Prime Preferred Stock

    2024-10-1515,002,1660 total(indirect: By 5AM Ventures VI, L.P.)
    Common Stock (1,337,592 underlying)
  • Conversion

    Series B Preferred Stock

    2024-10-154,244,7700 total(indirect: By 5AM Ventures VI, L.P.)
    Common Stock (378,463 underlying)
  • Conversion

    Series B Preferred Stock

    2024-10-153,395,8160 total(indirect: By 5AM Opportunities II, L.P.)
    Common Stock (302,770 underlying)
  • Conversion

    Common Stock

    2024-10-15+302,770302,770 total(indirect: By 5AM Opportunities II, L.P.)
Footnotes (3)
  • [F1]Each share of Series A Prime Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 11.2158-for-one basis without payment of further consideration. Immediately prior to the closing of the Issuer's initial public offering, the Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock had no expiration date.
  • [F2]The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.
  • [F3]The shares are directly held by 5AM Opportunities II, L.P. ("Opportunities II"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the sole general partner of Opportunities II. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities II GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities II. Each of Opportunities II GP and Dr. Parmar disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.

Issuer

Camp4 Therapeutics Corp

CIK 0001736730

Entity typeother

Related Parties

1
  • filerCIK 0001664281

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 5:56 PM ET
Size
23.2 KB